Roh JK - Search Results

1

Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.

Kim HS, Lee H, Jeung HC, Noh SH, Chung HC, Roh JK, Nam CM, Rha SY. Kim HS, et al. Among authors: roh jk. Jpn J Clin Oncol. 2011 Dec;41(12):1344-50. doi: 10.1093/jjco/hyr153. Jpn J Clin Oncol. 2011. PMID: 22128316

2

Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer.

Sohn JH, Jeung HC, Shin HJ, Rha SY, Roh JK, Noh SH, Min JS, Kim BS, Jang WI, Chung HC. Sohn JH, et al. Among authors: roh jk. Am J Clin Oncol. 2003 Apr;26(2):203-9. doi: 10.1097/00000421-200304000-00022. Am J Clin Oncol. 2003. PMID: 12714898 Clinical Trial.

3

A phase II study of infusional 5-fluorouracil and low-dose leucovorin with docetaxel for advanced gastric cancer.

Jeung HC, Rha SY, Kim YT, Noh SH, Roh JK, Chung HC. Jeung HC, et al. Among authors: roh jk. Oncology. 2006;70(1):63-70. doi: 10.1159/000091186. Epub 2006 Jan 27. Oncology. 2006. PMID: 16446551 Clinical Trial.

4

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer.

Jeung HC, Rha SY, Noh SH, Roh JK, Chung HC. Jeung HC, et al. Among authors: roh jk. Cancer Chemother Pharmacol. 2007 Feb;59(3):313-20. doi: 10.1007/s00280-006-0272-z. Epub 2006 Jun 13. Cancer Chemother Pharmacol. 2007. PMID: 16770582 Clinical Trial.

5

Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.

Moon YW, Jeung HC, Rha SY, Yoo NC, Roh JK, Noh SH, Kim BS, Chung HC. Moon YW, et al. Among authors: roh jk. Ann Surg Oncol. 2007 Oct;14(10):2730-7. doi: 10.1245/s10434-007-9479-4. Epub 2007 Jul 14. Ann Surg Oncol. 2007. PMID: 17632757

6

Bilateral breast cancer: differential diagnosis using histological and biological parameters.

Gong SJ, Rha SY, Jeung HC, Roh JK, Yang WI, Chung HC. Gong SJ, et al. Among authors: roh jk. Jpn J Clin Oncol. 2007 Jul;37(7):487-92. doi: 10.1093/jjco/hym056. Epub 2007 Aug 1. Jpn J Clin Oncol. 2007. PMID: 17673471

7

Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer.

Jeung HC, Rha SY, Park CH, Im CK, Shin SJ, Ahn JB, Noh SH, Roh JK, Chung HC. Jeung HC, et al. Among authors: roh jk. Int J Oncol. 2009 Mar;34(3):787-96. doi: 10.3892/ijo_00000204. Int J Oncol. 2009. PMID: 19212683 Clinical Trial.

8

A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer.

Im CK, Rha SY, Jeung HC, Ahn JB, Shin SJ, Noh SH, Roh JK, Chung HC. Im CK, et al. Among authors: roh jk. Am J Clin Oncol. 2010 Feb;33(1):56-60. doi: 10.1097/COC.0b013e31819fe216. Am J Clin Oncol. 2010. PMID: 19730355 Clinical Trial.

9

Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer.

Jeung HC, Rha SY, Shin SJ, Ahn JB, Noh SH, Roh JK, Chung HC. Jeung HC, et al. Among authors: roh jk. Jpn J Clin Oncol. 2010 Jan;40(1):29-35. doi: 10.1093/jjco/hyp124. Epub 2009 Oct 31. Jpn J Clin Oncol. 2010. PMID: 19880858 Free PMC article. Clinical Trial.

10

A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status.

Im CK, Rha SY, Jeung HC, Jeong J, Lee SH, Noh SH, Roh JK, Chung HC. Im CK, et al. Among authors: roh jk. Oncology. 2009;77(6):349-57. doi: 10.1159/000265941. Epub 2009 Dec 14. Oncology. 2009. PMID: 20016228 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters